Among patients with advanced liver fibrosis, patients who have high Fuc-Hp levels at EOT, high BMI, and low albumin levels at EOT should be carefully monitored for HCC occurrence after HCV elimination. This evidence concerns the gene ALB and hepatocellular carcinoma.